InvestorsHub Logo
Followers 68
Posts 823
Boards Moderated 0
Alias Born 03/19/2009

Re: None

Saturday, 01/02/2010 4:09:04 PM

Saturday, January 02, 2010 4:09:04 PM

Post# of 10802
RHGP(.98)...China/diagnostic kits.....

Potentially interesting situation regarding the diagnostic kits that China biotech/pharma RHGP has had under research and development. Cui Yuhai (RHGP's Chief R&D Officer) placed two ads in the last 2-3 weeks making it known that RHGP is actively looking to sell/transfer or enter into partnerships with regards to its diagnostic kits/technologies.

This could very well suggest that the R&D phase on at least some of the 30 diagnostic kits could be nearing completion. If I recall correctly, some of the promotional material a couple of years back mentioned that some of the kits were already in clinical trials. Perhaps this advertising could be an indication that things have been proceeding well in the China goverment approval process.

According to past SEC filings, during the R&D phase RHGP believed some of these kits were showing 50-60% improvements in both performance and cost versus the competition......

In order to explore possibilities in this field, a team of research scientists, who are graduates of top universities in the United States and therefore trained on the most advanced technology in this field, was hired in 2006 by us and our predecessor company. The Troponin T Diagnostic Kit and some other products from this group have proved to be 60% more effective at 50% less production cost when compared with other products.

http://knobias.10kwizard.com/filing.php?param=&ipage=5699859&DSEQ=1&SEQ=11&SQDESC=SECTION_PAGE&exp=

RHGP technology transfer advertisement.....

http://translate.googleusercontent.com/translate_c?hl=en&sl=zh-CN&u=http://www.jszrw.com/public/info.php%3Fid%3D1243&prev=/search%3Fq%3Dhttp://www.hrbrh.com/%26hl%3Den%26sa%3DN%26start%3D10&rurl=translate.google.com&twu=1&usg=ALkJrhiy1o3V4yWfDS1qJkzulwO-_nxjJA

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.